NeuroDex Overview
- Year Founded
-
2018
- Status
-
Private
- Employees
-
14
- Latest Deal Type
-
Later Stage VC
- Investors
-
9
NeuroDex General Information
Description
Developer of a blood-based diagnostics platform designed to diagnose neurodegenerative diseases. The company has developed neuron- and oligodendrocyte-derived extracellular vesicle isolation technologies, which are used to develop diagnostics for the leading indication of alpha-synuclein pathology, as well as for collaborations with life sciences companies and academia, enabling medical professionals to leverage advanced research in neurodegenerative diseases.
Contact Information
Website
www.neurodex.coCorporate Office
- 27 Strathmore Road
- Natick, MA 01760
- United States
Corporate Office
- 27 Strathmore Road
- Natick, MA 01760
- United States
NeuroDex Timeline
NeuroDex Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 10. Later Stage VC | 21-May-2024 | Completed | Generating Revenue | |||
| 9. Grant | 01-Jan-2024 | Completed | Generating Revenue | |||
| 8. Later Stage VC | 02-May-2023 | Completed | Generating Revenue | |||
| 7. Grant | 28-Mar-2023 | Completed | Generating Revenue | |||
| 6. Grant | 01-Jan-2023 | Completed | Product Development | |||
| 5. Seed Round | 22-Aug-2022 | Completed | Product Development | |||
| 4. Grant | 01-Jan-2022 | Completed | Startup | |||
| 3. Seed Round | 31-Jan-2020 | Completed | Startup | |||
| 2. Grant | 01-Jan-2019 | $212K | Completed | Startup | ||
| 1. Accelerator/Incubator | Completed | Startup |
NeuroDex Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Seed 1 | ||||||||
| Seed |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
NeuroDex Comparisons
Industry
Financing
Details
NeuroDex Competitors (2)
One of NeuroDex’s 2 competitors is Exosome Sciences, a Corporate Backed or Acquired company based in San Diego, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Exosome Sciences | Corporate Backed or Acquired | San Diego, CA | ||||
| Amprion (Biotechnology) | Venture Capital-Backed | San Francisco, CA |
NeuroDex Patents
NeuroDex Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026035725-A1 | Use of brain-derived exosomes in neurodegenerative diseases | Pending | 05-Aug-2024 | ||
| CA-3241305-A1 | Improved exosome profiling for therapy and diagnosis | Pending | 19-Dec-2021 | ||
| EP-4449121-A1 | Improved exosome profiling for therapy and diagnosis | Pending | 19-Dec-2021 | ||
| EP-4449121-A4 | Improved exosome profiling for therapy and diagnosis | Pending | 19-Dec-2021 | ||
| US-20250093343-A1 | Improved exosome profiling for therapy and diagnosis | Pending | 19-Dec-2021 | G01N33/54333 |
NeuroDex Signals
NeuroDex Investors (9)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| StartUp Health | Venture Capital | Minority | ||
| Alzheimers Drug Discovery Foundation | Not-For-Profit Venture Capital | |||
| Angel (individual) | Minority | |||
| Red Abbey Venture Partners | Venture Capital | Minority | ||
| U.S. Department of Health and Human Services | Government |
NeuroDex FAQs
-
When was NeuroDex founded?
NeuroDex was founded in 2018.
-
Where is NeuroDex headquartered?
NeuroDex is headquartered in Natick, MA.
-
What is the size of NeuroDex?
NeuroDex has 14 total employees.
-
What industry is NeuroDex in?
NeuroDex’s primary industry is Diagnostic Equipment.
-
Is NeuroDex a private or public company?
NeuroDex is a Private company.
-
What is NeuroDex’s current revenue?
The current revenue for NeuroDex is .
-
How much funding has NeuroDex raised over time?
NeuroDex has raised $1.66M.
-
Who are NeuroDex’s investors?
StartUp Health, Alzheimers Drug Discovery Foundation, , Red Abbey Venture Partners, and U.S. Department of Health and Human Services are 5 of 9 investors who have invested in NeuroDex.
-
Who are NeuroDex’s competitors?
Exosome Sciences and Amprion (Biotechnology) are competitors of NeuroDex.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process